Find Mesna manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

109RELATED EXCIPIENT COMPANIES

175EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 19767-45-4, Sodium 2-mercaptoethanesulfonate, Uromitexan, Mesnex, Mitexan, Mistabron
Molecular Formula
C2H5NaO3S2
Molecular Weight
164.18  g/mol
InChI Key
XOGTZOOQQBDUSI-UHFFFAOYSA-M
FDA UNII
NR7O1405Q9

Mesna
A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE.
1 2D Structure

Mesna

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;2-sulfanylethanesulfonate
2.1.2 InChI
InChI=1S/C2H6O3S2.Na/c3-7(4,5)2-1-6;/h6H,1-2H2,(H,3,4,5);/q;+1/p-1
2.1.3 InChI Key
XOGTZOOQQBDUSI-UHFFFAOYSA-M
2.1.4 Canonical SMILES
C(CS(=O)(=O)[O-])S.[Na+]
2.2 Other Identifiers
2.2.1 UNII
NR7O1405Q9
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2 Mercaptoethanesulfonate

2. 2-mercaptoethanesulfonate

3. 2-mercaptoethanesulphonate, Sodium

4. Asta D 7093

5. Asta-d 7093

6. Astad 7093

7. Coenzyme M

8. Ethanesulfonic Acid, 2-mercapto-, Monosodium Salt

9. Mesna Cell

10. Mesna-cell

11. Mesnex

12. Mesnum

13. Mistabron

14. Mistabronco

15. Mitexan

16. Mucofluid

17. Sodium 2-mercaptoethanesulphonate

18. Ucb 3983

19. Ucb-3983

20. Ucb3983

21. Uromitexan

22. Ziken

2.3.2 Depositor-Supplied Synonyms

1. 19767-45-4

2. Sodium 2-mercaptoethanesulfonate

3. Uromitexan

4. Mesnex

5. Mitexan

6. Mistabron

7. Mesnum

8. 2-mercaptoethanesulfonic Acid Sodium Salt

9. Mistabronco

10. Sodium 2-mercaptoethane Sulfonate

11. Ethanesulfonic Acid, 2-mercapto-, Monosodium Salt

12. Coenzyme M Sodium Salt

13. Sodium;2-sulfanylethanesulfonate

14. 2-mercaptoethanesulfonate, Sodium

15. 2-mercaptoethanesulfonic Acid Sodium

16. Sodium 2-mercaptoethanesulfonate;mesnum

17. Sodium 2-sulfanylethane-1-sulfonate

18. D 7093

19. D-7093

20. Nr7o1405q9

21. Nsc-113891

22. Ncgc00181166-01

23. Dsstox_cid_809

24. Dsstox_rid_75800

25. Dsstox_gsid_20809

26. Mesnum [inn-latin]

27. Smr000059219

28. Cas-19767-45-4

29. Natrium 2-mercaptoethansulfonat

30. Ccris 3712

31. 2-mercaptoethane Sulfonate Sodium

32. Sodium 2-mercaptoethanesulphonate

33. Einecs 243-285-9

34. Nsc 113891

35. Unii-nr7o1405q9

36. 2-mercapto-ethan-sulfonsaeure, Natrium-salz

37. 2-mercaptoethanesulfonic Acid Monosodium Salt

38. Mesna [usan:usp:inn:ban]

39. Uromitexan (tn)

40. Sodium 2-mercaptoethane-1-sulfonate

41. Mesnex (tn)

42. Mfcd00007535

43. Prestwick_1005

44. Mesna [vandf]

45. Mesna [usan]

46. Spectrum2_000752

47. Spectrum3_001483

48. Spectrum4_000041

49. Spectrum5_001174

50. Mesna [inn]

51. Mesna [jan]

52. Mesna [who-dd]

53. Mesna [mart.]

54. Mesna [mi]

55. Mesna (jan/usp/inn)

56. Chembl975

57. Schembl7993

58. Mesna (uromitexan, Mesnex)

59. Mesna [orange Book]

60. Kbiogr_000501

61. Mesna [ep Monograph]

62. Mesna [usp Impurity]

63. Mls001074691

64. Mls001333251

65. Mls001333252

66. Mesna [usp Monograph]

67. Spectrum1502014

68. Sodium2-mercaptoethanesulfonate

69. Spbio_000764

70. Dtxsid1020809

71. Chebi:31824

72. Hms502f17

73. Kbio3_002565

74. Hms1921d10

75. Hms2092n09

76. Hms2236l05

77. Hms3259d13

78. Hms3372m11

79. Hms3655m06

80. Hms3715h05

81. Sodium, 2-mercapto-ethanesulfonate

82. Bcp14384

83. Tox21_112767

84. Tox21_200863

85. Bdbm50247978

86. Ccg-40134

87. S1735

88. Akos006220661

89. Akos015960755

90. Tox21_112767_1

91. Ac-6011

92. Cs-1364

93. Nc00648

94. Ncgc00094939-01

95. Ncgc00094939-02

96. Ncgc00178318-04

97. Ncgc00258417-01

98. Sodium 2-sulphanylethanesulphonate

99. 2-mercaptoethanesulphonic Acid Sodium Salt

100. As-13260

101. Hy-13679

102. Db-044962

103. A8469

104. M0913

105. Sw199618-2

106. En300-49858

107. D01459

108. Ab01274734-01

109. Q424997

110. W-60283

111. Q-201713

112. 3-aminooxy-n-propyl(dimethyl-t-butylsilyl)ether

113. Z1741968275

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 164.18 g/mol
Molecular Formula C2H5NaO3S2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass163.95778065 g/mol
Monoisotopic Mass163.95778065 g/mol
Topological Polar Surface Area66.6 Ų
Heavy Atom Count8
Formal Charge0
Complexity123
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameMesna
PubMed HealthMesna
Drug ClassesHemorrhagic Cystitis Inhibitor
Drug LabelMesna is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide. The active ingredient mesna is a synthetic sulfhydryl compound designated as sodium-2-mercaptoethane sulfonate with a molecular formula of C2H5NaO3S2 and a molecu...
Active IngredientMesna
Dosage FormInjectable
Routeinjection; Intravenous
Strength1g/10ml; 100mg/ml
Market StatusPrescription
CompanyTeva Pharms Usa; Fresenius Kabi Usa; Mylan Institutional; Sagent Pharms; Eurohlth Intl; Agila Speclts

2 of 4  
Drug NameMesnex
PubMed HealthMesna (By mouth)
Drug ClassesHemorrhagic Cystitis Inhibitor
Drug LabelMesna is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide (IFEX). The active ingredient mesna is a synthetic sulfhydryl compound designated as sodium-2-mercaptoethane sulfonate with a molecular formula of C2H5NaO3S2 and a...
Active IngredientMesna
Dosage FormTablet; Injectable
RouteOral; Intravenous
Strength400mg; 100mg/ml
Market StatusPrescription
CompanyBaxter Hlthcare

3 of 4  
Drug NameMesna
PubMed HealthMesna
Drug ClassesHemorrhagic Cystitis Inhibitor
Drug LabelMesna is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide. The active ingredient mesna is a synthetic sulfhydryl compound designated as sodium-2-mercaptoethane sulfonate with a molecular formula of C2H5NaO3S2 and a molecu...
Active IngredientMesna
Dosage FormInjectable
Routeinjection; Intravenous
Strength1g/10ml; 100mg/ml
Market StatusPrescription
CompanyTeva Pharms Usa; Fresenius Kabi Usa; Mylan Institutional; Sagent Pharms; Eurohlth Intl; Agila Speclts

4 of 4  
Drug NameMesnex
PubMed HealthMesna (By mouth)
Drug ClassesHemorrhagic Cystitis Inhibitor
Drug LabelMesna is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide (IFEX). The active ingredient mesna is a synthetic sulfhydryl compound designated as sodium-2-mercaptoethane sulfonate with a molecular formula of C2H5NaO3S2 and a...
Active IngredientMesna
Dosage FormTablet; Injectable
RouteOral; Intravenous
Strength400mg; 100mg/ml
Market StatusPrescription
CompanyBaxter Hlthcare

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Protective Agents

Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. (See all compounds classified as Protective Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Cytoprotective Agent [EPC]
5.3 ATC Code

R - Respiratory system

R05 - Cough and cold preparations

R05C - Expectorants, excl. combinations with cough suppressants

R05CB - Mucolytics

R05CB05 - Mesna


V - Various

V03 - All other therapeutic products

V03A - All other therapeutic products

V03AF - Detoxifying agents for antineoplastic treatment

V03AF01 - Mesna


API SUPPLIERS

read-more
read-more

01

Aarti Pharmalabs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Flag India
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT arrow-down
Aarti Industries Company Banner

02

Sumar Biotech

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Sumar Biotech

03

Suzhou Ryway Biotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Suzhou Ryway Biotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT arrow-down
blank

05

Baxter Healthcare Corporation

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Baxter Healthcare Corporation

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT
blank

06

Solara Active Pharma Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Solara Active Pharma Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT arrow-down
blank

07

UCB Pharma S.A

Belgium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

UCB Pharma S.A

Belgium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

SIMS Srl

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

SIMS Srl

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

09

LIANYUNGANG GUIKE PHARMACEUTICAL

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

LIANYUNGANG GUIKE PHARMACEUTICAL

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Jiangsu Hengrui Medicine

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Jiangsu Hengrui Medicine

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Co-Processed Excipients

read-more
read-more

Solubilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Coating Systems & Additives

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Parenteral

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 19767-45-4 / Mesna API manufacturers, exporters & distributors?

Mesna manufacturers, exporters & distributors 1

74

PharmaCompass offers a list of Mesna API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mesna manufacturer or Mesna supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mesna manufacturer or Mesna supplier.

API | Excipient name

Mesna

Synonyms

19767-45-4, Sodium 2-mercaptoethanesulfonate, Uromitexan, Mesnex, Mitexan, Mistabron

Cas Number

19767-45-4

Unique Ingredient Identifier (UNII)

NR7O1405Q9

About Mesna

A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE.

Sodium 2-mercaptoethanesulfonate Manufacturers

A Sodium 2-mercaptoethanesulfonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium 2-mercaptoethanesulfonate, including repackagers and relabelers. The FDA regulates Sodium 2-mercaptoethanesulfonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium 2-mercaptoethanesulfonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Sodium 2-mercaptoethanesulfonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Sodium 2-mercaptoethanesulfonate Suppliers

A Sodium 2-mercaptoethanesulfonate supplier is an individual or a company that provides Sodium 2-mercaptoethanesulfonate active pharmaceutical ingredient (API) or Sodium 2-mercaptoethanesulfonate finished formulations upon request. The Sodium 2-mercaptoethanesulfonate suppliers may include Sodium 2-mercaptoethanesulfonate API manufacturers, exporters, distributors and traders.

click here to find a list of Sodium 2-mercaptoethanesulfonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Sodium 2-mercaptoethanesulfonate USDMF

A Sodium 2-mercaptoethanesulfonate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium 2-mercaptoethanesulfonate active pharmaceutical ingredient (API) in detail. Different forms of Sodium 2-mercaptoethanesulfonate DMFs exist exist since differing nations have different regulations, such as Sodium 2-mercaptoethanesulfonate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Sodium 2-mercaptoethanesulfonate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium 2-mercaptoethanesulfonate USDMF includes data on Sodium 2-mercaptoethanesulfonate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium 2-mercaptoethanesulfonate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Sodium 2-mercaptoethanesulfonate suppliers with USDMF on PharmaCompass.

Sodium 2-mercaptoethanesulfonate JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Sodium 2-mercaptoethanesulfonate Drug Master File in Japan (Sodium 2-mercaptoethanesulfonate JDMF) empowers Sodium 2-mercaptoethanesulfonate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Sodium 2-mercaptoethanesulfonate JDMF during the approval evaluation for pharmaceutical products. At the time of Sodium 2-mercaptoethanesulfonate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Sodium 2-mercaptoethanesulfonate suppliers with JDMF on PharmaCompass.

Sodium 2-mercaptoethanesulfonate CEP

A Sodium 2-mercaptoethanesulfonate CEP of the European Pharmacopoeia monograph is often referred to as a Sodium 2-mercaptoethanesulfonate Certificate of Suitability (COS). The purpose of a Sodium 2-mercaptoethanesulfonate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sodium 2-mercaptoethanesulfonate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sodium 2-mercaptoethanesulfonate to their clients by showing that a Sodium 2-mercaptoethanesulfonate CEP has been issued for it. The manufacturer submits a Sodium 2-mercaptoethanesulfonate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sodium 2-mercaptoethanesulfonate CEP holder for the record. Additionally, the data presented in the Sodium 2-mercaptoethanesulfonate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sodium 2-mercaptoethanesulfonate DMF.

A Sodium 2-mercaptoethanesulfonate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sodium 2-mercaptoethanesulfonate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Sodium 2-mercaptoethanesulfonate suppliers with CEP (COS) on PharmaCompass.

Sodium 2-mercaptoethanesulfonate WC

A Sodium 2-mercaptoethanesulfonate written confirmation (Sodium 2-mercaptoethanesulfonate WC) is an official document issued by a regulatory agency to a Sodium 2-mercaptoethanesulfonate manufacturer, verifying that the manufacturing facility of a Sodium 2-mercaptoethanesulfonate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sodium 2-mercaptoethanesulfonate APIs or Sodium 2-mercaptoethanesulfonate finished pharmaceutical products to another nation, regulatory agencies frequently require a Sodium 2-mercaptoethanesulfonate WC (written confirmation) as part of the regulatory process.

click here to find a list of Sodium 2-mercaptoethanesulfonate suppliers with Written Confirmation (WC) on PharmaCompass.

Sodium 2-mercaptoethanesulfonate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium 2-mercaptoethanesulfonate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Sodium 2-mercaptoethanesulfonate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Sodium 2-mercaptoethanesulfonate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Sodium 2-mercaptoethanesulfonate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium 2-mercaptoethanesulfonate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Sodium 2-mercaptoethanesulfonate suppliers with NDC on PharmaCompass.

Sodium 2-mercaptoethanesulfonate GMP

Sodium 2-mercaptoethanesulfonate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Sodium 2-mercaptoethanesulfonate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sodium 2-mercaptoethanesulfonate GMP manufacturer or Sodium 2-mercaptoethanesulfonate GMP API supplier for your needs.

Sodium 2-mercaptoethanesulfonate CoA

A Sodium 2-mercaptoethanesulfonate CoA (Certificate of Analysis) is a formal document that attests to Sodium 2-mercaptoethanesulfonate's compliance with Sodium 2-mercaptoethanesulfonate specifications and serves as a tool for batch-level quality control.

Sodium 2-mercaptoethanesulfonate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium 2-mercaptoethanesulfonate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Sodium 2-mercaptoethanesulfonate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium 2-mercaptoethanesulfonate EP), Sodium 2-mercaptoethanesulfonate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium 2-mercaptoethanesulfonate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty